SIRT2 and leukemia: To test the preference of SIRT2 inhibitors, we isolated normal hematopoietic stem and progenitor cells (HSPCs) and found that SIRT2-specific inhibitors (AGK2 and SirReal2) selectively decreased the proliferation of mouse leukaemia cell RAW264.7, but not HSPCs (Fig. 6m,n).